Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts

Last updated: August 29, 2022
Sponsor: Sohag University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Warts

Treatment

N/A

Clinical Study ID

NCT05520658
Soh-Med-22-07-01
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Warts are common skin infections caused by human papillomavirus (HPV), which can cause a variety of skin presentations according to its type, site and the immune status .Nongenital warts may be presented as common, plane, plantar, filiform, or mucosal warts .Most people are affected by cutaneous warts, either plantar warts or common warts .prevalence of skin warts is between 3% and 13% and plantar warts are about 30% of skin warts in western world .Majority of cases occur in adolescent and young adults

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age:>18 years .
  • Sex: both males and females will be included.
  • Confirmed diagnosis by clinical and dermoscopic examination of plantar warts will bemade

Exclusion

Exclusion Criteria:

  • Patients with history or evidenced hypersensitivity to any component used in thisstudy.
  • Pregnancy & lactating.
  • Patients who receive immune suppressive therapy.
  • Patients who receive any wart treatment during the last 2 months before enrollment inthe study.
  • Patients with systemic illness especially cardiac patients.
  • Patients who refused participation in the study

Study Design

Total Participants: 60
Study Start date:
July 01, 2022
Estimated Completion Date:
September 30, 2022

Connect with a study center

  • Sohag University Hospital

    Sohag,
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.